Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226741 | SCV000287428 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-07-18 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000415142 | SCV000492556 | uncertain significance | Primary dilated cardiomyopathy; Migraine; Hemiplegia | 2014-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338720 | SCV002636331 | likely benign | Cardiovascular phenotype | 2020-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001701711 | SCV005326944 | uncertain significance | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome Diagnostics Laboratory, |
RCV001701711 | SCV001931820 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701711 | SCV001951184 | likely benign | not provided | no assertion criteria provided | clinical testing |